-
1
-
-
33747334754
-
-
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, D.C.: American Psychiatric Association, 1994.
-
-
-
-
4
-
-
0003558472
-
-
The Guilford Press, New York
-
DuPaul G.J., Power T.J., Anastopoulos A.D., and Reid R. ADHD rating scale-IV. Checklist, norms, and clinical interpretations (1998), The Guilford Press, New York
-
(1998)
ADHD rating scale-IV. Checklist, norms, and clinical interpretations
-
-
DuPaul, G.J.1
Power, T.J.2
Anastopoulos, A.D.3
Reid, R.4
-
6
-
-
0037485237
-
Validation of the ADHD rating scale as a clinician administered and scored instrument
-
Faries D.E., Yalcin I., Harder D., and Heiligenstein J.H. Validation of the ADHD rating scale as a clinician administered and scored instrument. J Atten Disord 5 (2001) 107-115
-
(2001)
J Atten Disord
, vol.5
, pp. 107-115
-
-
Faries, D.E.1
Yalcin, I.2
Harder, D.3
Heiligenstein, J.H.4
-
7
-
-
0023807173
-
Motor performance in hyperactive children treated with imipramine
-
Gualtieri C.T., and Evans R.W. Motor performance in hyperactive children treated with imipramine. Percept Mot Skills 66 (1988) 763-769
-
(1988)
Percept Mot Skills
, vol.66
, pp. 763-769
-
-
Gualtieri, C.T.1
Evans, R.W.2
-
8
-
-
0042825435
-
Comparative efficacy of two once daily methylphenidate formulations (Ritalin LA and Concerta) and placebo in children with attention deficit hyperactivity disorder across the school day
-
Lopez F., Silva R., Pestreich L., and Muniz R. Comparative efficacy of two once daily methylphenidate formulations (Ritalin LA and Concerta) and placebo in children with attention deficit hyperactivity disorder across the school day. Paediatr Drugs 5 (2003) 545-555
-
(2003)
Paediatr Drugs
, vol.5
, pp. 545-555
-
-
Lopez, F.1
Silva, R.2
Pestreich, L.3
Muniz, R.4
-
9
-
-
17544402536
-
Once-a day-concerta methylphendiate versus three-times-daily methylphenidate in laboratory and natural settings
-
Pelham W.E., Gnagy E.M., Burrows-Maclean L., Williams A., Fabiano G.A., Morrissey S.M., et al. Once-a day-concerta methylphendiate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics 107 (2001) E105
-
(2001)
Pediatrics
, vol.107
-
-
Pelham, W.E.1
Gnagy, E.M.2
Burrows-Maclean, L.3
Williams, A.4
Fabiano, G.A.5
Morrissey, S.M.6
-
10
-
-
0027074851
-
The P300 wave of the Human Event-Related Potential
-
Picton T.W. The P300 wave of the Human Event-Related Potential. J Clin Neurophysiol 9 (1992) 456-479
-
(1992)
J Clin Neurophysiol
, vol.9
, pp. 456-479
-
-
Picton, T.W.1
-
11
-
-
0016604841
-
One-year follow-up of hyperactive boys treated with imipramine or methylphenidate
-
Quinn P.O., and Rapoport J.L. One-year follow-up of hyperactive boys treated with imipramine or methylphenidate. Am J Psychiatry 132 (1975) 241-245
-
(1975)
Am J Psychiatry
, vol.132
, pp. 241-245
-
-
Quinn, P.O.1
Rapoport, J.L.2
-
12
-
-
0029150215
-
Abnormal Auditory P300 Topography in Attention Deficit Disorder predicts Poor Response to Pemoline
-
Sangal J.M., Sangal R.B., and Persky B. Abnormal Auditory P300 Topography in Attention Deficit Disorder predicts Poor Response to Pemoline. Clin Electroencephal 26 (1995) 204-213
-
(1995)
Clin Electroencephal
, vol.26
, pp. 204-213
-
-
Sangal, J.M.1
Sangal, R.B.2
Persky, B.3
-
13
-
-
0029830367
-
Prolonged P300 latency in attention deficit hyperactivity disorder predicts poor response to imipramine
-
Sangal J.M., Sangal R.B., and Persky B. Prolonged P300 latency in attention deficit hyperactivity disorder predicts poor response to imipramine. Clin Electroencephal 27 (1996) 191-201
-
(1996)
Clin Electroencephal
, vol.27
, pp. 191-201
-
-
Sangal, J.M.1
Sangal, R.B.2
Persky, B.3
-
14
-
-
0345797928
-
What is a significant response in drug studies of attention-deficit/hyperactivity disorder: statistical significance is necessary, but is it sufficient?
-
Sangal R.B., and Sangal J.M. What is a significant response in drug studies of attention-deficit/hyperactivity disorder: statistical significance is necessary, but is it sufficient?. Psychopharmacol Bull 37 (2003) 50-58
-
(2003)
Psychopharmacol Bull
, vol.37
, pp. 50-58
-
-
Sangal, R.B.1
Sangal, J.M.2
-
15
-
-
0347990368
-
attention-deficit/hyperactivity disorder: cognitive evoked potential (p300) topography predicts treatment response to methylphenidate
-
Sangal J.M., and Sangal R.B. attention-deficit/hyperactivity disorder: cognitive evoked potential (p300) topography predicts treatment response to methylphenidate. Clin Neurophysiol 115 (2004) 188-193
-
(2004)
Clin Neurophysiol
, vol.115
, pp. 188-193
-
-
Sangal, J.M.1
Sangal, R.B.2
-
16
-
-
13844276613
-
Attention-deficit/hyperactivity disorder: cognitive evoked potential (P300) amplitude predicts treatment response to atomoxetine
-
Sangal R.B., and Sangal J.M. Attention-deficit/hyperactivity disorder: cognitive evoked potential (P300) amplitude predicts treatment response to atomoxetine. Clin Neurophysiol 116 (2005) 640-647
-
(2005)
Clin Neurophysiol
, vol.116
, pp. 640-647
-
-
Sangal, R.B.1
Sangal, J.M.2
-
17
-
-
0004032635
-
-
American EEG Society, Bloomfield, CT
-
Sharbrough F., Chatrian G., Lesser R.P., et al. Guidelines for standard electrode position nomenclature (1990), American EEG Society, Bloomfield, CT
-
(1990)
Guidelines for standard electrode position nomenclature
-
-
Sharbrough, F.1
Chatrian, G.2
Lesser, R.P.3
|